AfterMaster (AFTM) 10-Q 16 Nov 17 2018 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Sep. 30, 2017	Nov. 15, 2017
Document And Entity Information
Entity Registrant Name	AFTERMASTER, INC.
Entity Central Index Key	836,809
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		122,674,082
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,018

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2017	Jun. 30, 2017
Current Assets
Cash	$ 86,634	$ 250,728
Accounts receivable	552,877	97,103
Inventory, net	206,548	104,891
Available for sale securities	47,940	123,600
Prepaid expenses	462,720	507,254
Total Current Assets	1,356,719	1,083,576
Property and equipment, net	235,252	266,040
Intangible assets, net	97,758	102,243
Deposits	33,363	33,363
Prepaid expenses, net of current	0	9,104
Total Assets	1,723,092	1,494,326
Current Liabilities
Accounts payable and other accrued expenses	518,642	459,975
Accrued interest	351,336	185,509
Deferred revenue	266,692	270,623
Accrued consulting services - related party	33,449	22,064
Lease payable	0	1,937
Derivative liability	2,932,616	2,145,065
Notes payable - related party	618,000	610,000
Notes payable, net of discount $29,744 and $0, respectively	195,744	40,488
Convertible notes payable - related party, net of discount of $0 and $3,818, respectively	3,955,000	3,951,182
Convertible notes payable, net of discount of $622,677 and $549,737, respectively	2,470,073	2,267,845
Total Current Liabilities	11,341,552	9,954,688
Total Liabilities	11,341,552	9,954,688
Stockholders' Deficit
Common stock, authorized 250,000,000 shares, par value $0.001, 122,674,082 and 118,486,728 shares issued and outstanding, respectively	122,681	118,493
Additional paid in capital	64,256,052	63,627,987
Accumulated other comprehensive income	17,940	93,600
Accumulated deficit	(74,018,242)	(72,303,551)
Total Stockholders' Deficit	(9,618,460)	(8,460,362)
Total Liabilities and Stockholders' Deficit	1,723,092	1,494,326
Series A Convertible Preferred stock
Stockholders' Deficit
Preferred stock	16	16
Series A-1 Convertible Preferred stock
Stockholders' Deficit
Preferred stock	2,585	2,585
Series B Convertible Preferred stock
Stockholders' Deficit
Preferred stock	3	3
Series C Convertible Preferred stock
Stockholders' Deficit
Preferred stock	13	13
Series D Convertible Preferred stock
Stockholders' Deficit
Preferred stock	130	130
Series E Convertible Preferred stock
Stockholders' Deficit
Preferred stock	275	275
Series P Convertible Preferred stock
Stockholders' Deficit
Preferred stock	87	87
Series S Convertible Preferred stock
Stockholders' Deficit
Preferred stock	$ 0	$ 0

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2017	Jun. 30, 2017
LIABILITIES AND STOCKHOLDERS' EQUITY
Discount on notes payable	$ 29,744	$ 0
Discount on related party convertible notes payable, current	0	3,818
Discount on convertible notes payable	$ 622,677	$ 549,737
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized shares	250,000,000	250,000,000
Common stock, issued shares	122,674,082	118,486,728
Common stock, outstanding shares	122,674,082	118,486,728
Series A Convertible Preferred stock
LIABILITIES AND STOCKHOLDERS' EQUITY
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, authorized shares	100,000	100,000
Convertible preferred stock, issued shares	15,500	15,500
Convertible preferred stock, outstanding shares	15,500	15,500
Series A-1 Convertible Preferred stock
LIABILITIES AND STOCKHOLDERS' EQUITY
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, authorized shares	3,000,000	3,000,000
Convertible preferred stock, issued shares	2,585,000	2,185,000
Convertible preferred stock, outstanding shares	2,585,000	2,185,000
Series B Convertible Preferred stock
LIABILITIES AND STOCKHOLDERS' EQUITY
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, authorized shares	200,000	200,000
Convertible preferred stock, issued shares	3,500	3,500
Convertible preferred stock, outstanding shares	3,500	3,500
Series C Convertible Preferred stock
LIABILITIES AND STOCKHOLDERS' EQUITY
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, authorized shares	1,000,000	1,000,000
Convertible preferred stock, issued shares	13,404	13,404
Convertible preferred stock, outstanding shares	13,404	13,404
Series D Convertible Preferred stock
LIABILITIES AND STOCKHOLDERS' EQUITY
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, authorized shares	375,000	375,000
Convertible preferred stock, issued shares	130,000	130,000
Convertible preferred stock, outstanding shares	130,000	130,000
Series E Convertible Preferred stock
LIABILITIES AND STOCKHOLDERS' EQUITY
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, authorized shares	1,000,000	1,000,000
Convertible preferred stock, issued shares	275,000	275,000
Convertible preferred stock, outstanding shares	275,000	275,000
Series P Convertible Preferred stock
LIABILITIES AND STOCKHOLDERS' EQUITY
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, authorized shares	600,000	600,000
Convertible preferred stock, issued shares	86,640	86,640
Convertible preferred stock, outstanding shares	86,640	86,640
Series S Convertible Preferred stock
LIABILITIES AND STOCKHOLDERS' EQUITY
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, authorized shares	50,000	50,000
Convertible preferred stock, issued shares	0	0
Convertible preferred stock, outstanding shares	0	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
REVENUES
AfterMaster Revenues	$ 120,715	$ 54,486
AfterMaster Product Revenues	494,681	0
Total Revenues	615,396	54,486
COSTS AND EXPENSES
Cost of Revenues (Exclusive of Depreciation and Amortization)	156,328	162,095
Depreciation and Amortization Expense	38,969	40,539
Research and Development	2,194	66,995
Advertising and Promotion Expense	2,016	15,079
Legal and Professional Expense	14,190	24,266
Non-Cash Consulting Expense	76,438	871,971
General and Administrative Expenses	786,990	712,836
Total Costs and Expenses	1,077,125	1,893,781
Loss from Operations	(461,729)	(1,839,295)
Other Expense
Interest Expense	(875,313)	(369,073)
Derivative Expense	(133,652)	0
Change in Fair Value of Derivative	(209,039)	(111)
Loss on Extinguishment of Debt	(34,958)	0
Total Other Expense	(1,252,962)	(369,184)
Loss Before Income Taxes	(1,714,691)	(2,208,479)
Income Tax Expense	0	0
NET LOSS	(1,714,691)	(2,208,479)
Preferred Stock Accretion and Dividends	(56,367)	(42,238)
NET LOSS AVAILABLE TO COMMON SHAREHOLDERS	$ (1,771,058)	$ (2,250,717)
Basic and diluted Loss Per Share of Common Stock	$ (0.01)	$ (0.02)
Weighted Average Number of Shares Outstanding	119,459,942	102,516,086
Other Comprehensive Income, net of tax
NET LOSS AVAILABLE TO COMMON SHAREHOLDERS	$ (1,771,058)	$ (2,250,717)
Unrealized gain on AFS Securities	(75,660)	23,400
COMPREHENSIVE LOSS	$ (1,846,718)	$ (2,227,317)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
OPERATING ACTIVITIES
Net Loss	$ (1,714,691)	$ (2,208,479)
Adjustments to reconcile net loss to cash from operating activities:
Depreciation and amortization	38,969	40,539
Share-based compensation - Common Stock	100,589	106,014
Common stock issued for services and rent	0	3,838
Common stock issued to extend the maturity dates on debt	16,897	60,000
Amortization of debt discount and issuance costs	418,126	92,241
Loss on extinguishment of debt	34,958	0
Derivative Expense	133,652	0
Gain remeasurement of derivative	209,039	111
Changes in Operating Assets and Liabilities:
Accounts receivable	(455,774)	(4,606)
Inventory	(101,657)	(41,333)
Other assets	76,438	745,431
Accounts payable and accrued expenses	64,084	124,414
Accrued interest	443,455	216,880
Deferred revenue	(3,931)	14,371
Accrued consulting services - related party	11,385	(697)
Net Cash Used in Operating Activities	(728,461)	(851,276)
INVESTING ACTIVITIES
Purchase of property and equipment	(546)	(53,353)
Purchase of intangible assets	(3,150)	(23,000)
Net Cash Used in Investing Activities	(3,696)	(76,353)
FINANCING ACTIVITIES
Common Stock issued for cash	168,500	0
A-1 Preferred Stock issued for cash	0	346,000
Proceeds from notes payable	175,000	0
Proceeds from notes payable - related party	18,000	0
Repayments of notes payable - related party	(10,000)	0
Proceeds from convertible notes payable	438,500	1,160,000
Repayments of convertible notes payable	(220,000)	0
Lease Payable	(1,937)	(984)
Net Cash Provided by Financing Activities	568,063	1,505,016
NET CHANGE IN CASH	(164,094)	577,387
CASH AT BEGINNING OF PERIOD	250,728	394,325
CASH AT END OF PERIOD	86,634	971,712
CASH PAID FOR:
Interest	0	0
Taxes	0	0
NON CASH FINANCING ACTIVITIES:
Beneficial conversion feature	30,000	30,519
Conversion of Notes and Interest into common stock	34,000	334,804
Conversion of preferred stock for common stock	0	200
Conversion of Derivative Liability	31,895	56,791
MTM on AFS securities	75,660	23,400
Common Stock issued with convertible debt	15,963	33,349
Common stock issued for prepaid expenses	22,800	118,250
Derivative Liability	435,778	56,680
Original Issue Discount	35,250	0
Conversion of accrued interest into common stock	$ 217,628	$ 0

1. CONDENSED FINANCIAL STATEMEN

1. CONDENSED FINANCIAL STATEMENTS	3 Months Ended
	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
1. CONDENSED FINANCIAL STATEMENTS	The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at September 30, 2017, and for all periods presented herein, have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's June 30, 2017 audited financial statements. The results of operations for the periods ended September 30, 2017 and 2016 are not necessarily indicative of the operating results for the full years.

2. GOING CONCERN

2. GOING CONCERN	3 Months Ended
	Sep. 30, 2017
Text Block [Abstract]
2. GOING CONCERN	The Company's financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has an accumulated deficit of $74,018,242, negative working capital of $9,984,833, and currently has revenues which are insufficient to cover its operating costs, which raises substantial doubt about its ability to continue as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The future of the Company as an operating business will depend on its ability to (1) obtain sufficient capital contributions and/or financing as may be required to sustain its operations and (2) to achieve adequate revenues from its ProMaster and AfterMaster businesses. Management's plan to address these issues includes, (a) continued exercise of tight cost controls to conserve cash, (b) obtaining additional financing, (c) more widely commercializing the AfterMaster and ProMaster products, and (d) identifying and executing on additional revenue generating opportunities. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

3. SUMMARY OF SIGNIFICANT ACCOU

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates are made in relation to the allowance for doubtful accounts and the fair value of certain financial instruments. Principles of Consolidation The consolidated financial statements include the accounts of AfterMaster, Inc. and its subsidiaries. All significant inter-Company accounts and transactions have been eliminated. Investments Our available for securities are considered Level 1. Realized gains and losses on these securities are included in “Other income (expense) – net” in the consolidated statements of operations using the specific identification method. Unrealized gains and losses, on available-for-sale securities are recorded in accumulated other comprehensive income (accumulated OCI). Unrealized losses that are considered other than temporary are recorded in other income (expense) – net, with the corresponding reduction to the carrying basis of the investment. Our short-term investments are recorded at amortized cost, and the respective carrying amounts approximate fair values. Our available for securities maturing within one year are recorded in “Other current assets,” on the balance sheets. Accounts Receivables Accounts receivables are stated at amounts management expects to collect. An allowance for doubtful accounts is provided for uncollectible receivables based upon management's evaluation of outstanding accounts receivable at each reporting period considering historical experience and customer credit quality and delinquency status. Delinquency status is determined by contractual terms. Bad debts are written off against the allowance when identified. Fair Value Instruments Cash is the Company’s only financial asset or liability required to be recognized at fair value and is measured using quoted prices for active markets for identical assets (Level 1 fair value hierarchy). The carrying amounts reported in the balance sheets for notes receivable and accounts payable and accrued expenses approximate their fair market value based on the short-term maturity of these instruments. Market prices are not available for the Company’s loans due to related parties or its other notes payable, nor are market prices of similar loans available. The Company determined that the fair value of the notes payable based on its amortized cost basis due to the short-term nature and current borrowing terms available to the Company for these instruments. Derivative Liabilities The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares. Using this sequencing policy, the Company used this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to July 5, 2016 until the note was converted on the same day were derivative liabilities. The Company again used this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to August 19, 2016 until the note was converted on August 22, 2016 were derivative liabilities. The Company entered into multiple amendments to a note payable to extend the maturity date (the Amendments). The Company agreed to additional $30,000 extension fees which were converted at a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. This creates a situation where the Company no longer has shares enough available to “cover” all potential equity issuance obligations during the period of issuance until conversion. On February 3, 2017, the company entered into a note payable with an unrelated party at a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. Accordingly, all convertible instruments issued after February 3, 2017 are considered derivatives according to the Company’s sequencing policy. The Company values these convertible notes payable using the multinomial lattice method that values the derivative liability within the notes based on a probability weighted discounted cash flow model. The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the statement of operations. Income Taxes There is no income tax provision for the three months ended September 30, 2017 and 2016 due to net operating losses for which there is no benefit currently available. At September 30, 2017, the Company had deferred tax assets associated with state and federal net operating losses. The Company has recorded a corresponding full valuation allowance as it is more likely than not that some portion of all of the deferred tax assets will not be realized. Revenue Recognition The Company applies the provisions of FASB ASC 605, Revenue Recognition in Financial Statements The Company's revenues are generated from AfterMaster products and services, AfterMaster Pro, sessions revenue, and remastering. Revenues related to AfterMaster Pro sells through consumer retail distribution channels and through our website. For sales through consumer retail distribution channels, revenue recognition occurs when title and risk of loss have transferred to the customer which usually occurs upon shipment to the customers. We established allowances for expected product returns and these allowances are recorded as a direct reduction to revenue. Return allowances are based on our historical experience. Revenues related to sessions and remastering are recognized when the event occured. Cost of Revenues The Company’s cost of revenues includes employee costs, and other nominal amounts. Costs associated with products are recognized at the time of the sale and when the inventory is shipped. Costs incurred to provide services are recognized as cost of sales as incurred. Depreciation is not included within cost of revenues. Loss Per Share Basic loss per Common Share is computed by dividing losses attributable to Common shareholders by the weighted-average number of shares of Common Stock outstanding during the period. The losses attributable to Common shareholders was increased for accrued and deemed dividends on Preferred Stock during the three months ended September 30, 2017 and 2016 of $56,367 and $42,238, respectively. Diluted earnings per Common Share is computed by dividing net loss attributable to Common shareholders by the weighted-average number of Shares of Common Stock outstanding during the period increased to include the number of additional Shares of Common Stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding convertible Preferred Stock, stock options, warrants, and convertible debt. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s Common Stock can result in a greater dilutive effect from potentially dilutive securities. For the three months ended September 30, 2017 and 2016, all of the Company’s potentially dilutive securities (warrants, options, convertible preferred stock, and convertible debt) were excluded from the computation of diluted earnings per share as they were anti-dilutive. The total number of potentially dilutive Common Shares that were excluded were 37,364,624 and 27,689,839 at September 30, 2017 and 2016, respectively. Recent Accounting Pronouncements Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

4. SECURITIES AVAILABLE-FOR-SAL

4. SECURITIES AVAILABLE-FOR-SALE	3 Months Ended
	Sep. 30, 2017
Securities Available-for-sale Tables
4. SECURITIES AVAILABLE-FOR-SALE	On November 10, 2014, the Company received 600,000 shares of b Booth stock as part of an Asset License agreement with b Booth. The following table presents the amortized cost, gross unrealized gains, gross unrealized losses, and fair market value of available-for-sale equity securities, nearly all of which are attributable to the Company's investment in b Booth stock, as follows: September 30, 2017 Amortized cost Gross unrealized gains Gross unrealized losses Gross realized gains Gross realized losses Fair value Equity securities $ 123,600 $ (75,660 ) $ - $ - $ - $ 47,940 June 30, 2017 Amortized cost Gross unrealized gains Gross unrealized losses Gross realized gains Gross realized losses Fair value Equity securities $ 63,600 $ 60,000 $ - $ - $ - $ 123,600

5. NOTES PAYABLE

5. NOTES PAYABLE	3 Months Ended
	Sep. 30, 2017
Notes Payable [Abstract]
5. NOTES PAYABLE	Convertible Notes Payable In accounting for its convertible notes payable, proceeds from the sale of a convertible debt instrument with Common Stock purchase warrants are allocated to the two elements based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portions of the proceeds allocated to the warrants are accounted for as paid-in capital with an offset to debt discount. The remainder of the proceeds are allocated to the debt instrument portion of the transaction as prescribed by ASC 470-25-20. The Company then calculates the effective conversion price of the note based on the relative fair value allocated to the debt instrument to determine the fair value of any beneficial conversion feature (“BCF”) associated with the convertible note in accordance with ASC 470-20-30. The BCF is recorded to additional paid-in capital with an offset to debt discount. Both the debt discount related to the issuance of warrants and related to a BCF is amortized over the life of the note. Convertible Notes Payable – Related Parties Convertible notes payable due to related parties consisted of the following as of September 30, 2017 and June 30, 2017, respectively: Convertible Notes Payable – Related Parties September 30, June 30, 2017 2017 Various term notes with total face value of $3,925,000 issued from February 2010 to April 2013, interest rates range from 10% to 15%, net of unamortized discount of $0 as of September 30, 2017 and June 30, 2017. $ 3,925,000 $ 3,925,000 $30,000 face value, issued in August 2016, interest rate of 0%, matures January 2017, a gain on extinguishment of debt was recorded totaling $3,818 net unamortized discount of $0 as of September 30, 2017 and June 30, 2017. 30,000 26,182 Total convertible notes payable – related parties 3,955,000 3,951,182 Less current portion 3,955,000 3,951,182 Convertible notes payable – related parties, long-term $ - $ - Convertible Notes Payable - Non-Related Parties Convertible notes payable due to non-related parties consisted of the following as of September 30, 2017 and June 30, 2017, respectively: Convertible Notes Payable - Non-Related Parties September 30, June 30, 2017 2017 $7,000 face value, issued in July 2014, interest rate of 6%, matures October 2017, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. $ 7,000 $ 7,000 $600,000 face value, issued in November 2015, interest rate of 0%, an OID of $190,000, matures November 2017, net unamortized discount of $0 of J September 30, 2017 and June 30, 2017, respectively, of which $260,000 has been paid. 430,000 430,000 $100,000 face value, issued in February 2016, interest rate of 10%, matures March 2018, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. 100,000 100,000 $25,000 face value, issued in February 2016, interest rate of 10%, matures February 2017, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. 25,000 25,000 $100,000 face value, issued in March 2016, interest rate of 10%, matures June2017, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. 100,000 100,000 $10,000 face value, issued in March 2016, interest rate of 10%, matures March 2018, net unamortized discount $0 of September 30, 2017 and June 30, 2017, respectively. 10,000 10,000 $50,000 face value, issued in July 2016, interest rate of 0%, matures October 2017, net unamortized discount of $0 of September 30, 2017 and June 30, 2017, respectively. 50,000 50,000 $50,000 face value, issued in August 2016, interest rate of 0%, matures September which was amended to January 2018, net unamortized discount of $44,308 and $5,418 of September 30, 2017 and June 30, 2017, respectively. 5,692 44,582 $1,000,000 face value, issued in September 2016, interest rate of 10%, matures June 2017, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. 1,000,000 1,000,000 $149,000 face value, issued in February 2017, interest rate of 10%, matures November 2017, net amortized discount of $0 and $59,740 as of September 30, 2017 and June 30, 2017, respectively, of which $20,000 has been paid. 129,000 89,260 $224,000 face value, issued in February 2017, interest rate of 10%, matures November 2017, net amortized discount of $32,452 and $119,795 as of September 30, 2017 and June 30, 2017, respectively, of which $15,000 has been paid. 176,548 104,205 $258,000 face value, issued in February 2017, interest rate of 12%, matures August 2017, net amortized discount of $0 and $48,464 as of September 30, 2017 and June 30, 2017, respectively, of which $185,000 has been paid. 133,000 209,536 $55,000 face value, issued in June 2017, interest rate of 10%, matures January 2018, net amortized discount of $26,986 and $50,631 as of September 30, 2017 and June 30, 2017, respectively. 28,014 4,369 $100,000 face value, issued in June 2017, interest rate of 7%, matures June 2018, net amortized discount of $39,130 and $52,317 as of September 30, 2017 and June 30, 2017, respectively. 60,870 47,683 $265,000 face value, issued in May 2017, interest rate of 10%, matures February 2018, net amortized discount of $132,028 and $218,790 as of September 30, 2017 and June 30, 2017, respectively. 132,972 46,210 $78,000 face value, issued in July 2017, interest rate of 12%, matures May 2018, net amortized discount of $61,187 as of September 30, 2017. 16,813 - $50,000 face value, issued in August 2017, interest rate of 0%, matures October 2017, net amortized discount of $0 as of September 30, 2017, of which $34,000 has been converted. 16,000 - $60,500 face value, issued in August 2017, interest rate of 12%, matures August 2018, net amortized discount of $50,721 as of September 30, 2017. 9,779 - $10,000 face value, issued in August 2017, interest rate of 0%, matures August 2018, net amortized discount of $8,204 as of September 30, 2017. 1,796 - $82,250 face value, issued in August 2017, interest rate of 12%, matures May 2018, net amortized discount of $68,542 as of September 30, 2017. 13,708 - $53,000 face value, issued in August 2017, interest rate of 12%, matures June 2018, net amortized discount of $45,155 as of September 30, 2017. 7,845 - $65,000 face value, issued in September 2017, interest rate of 12%, matures March 2018, net amortized discount of $57,099 as of September 30, 2017. 7,901 - $10,000 face value, issued in September 2017, interest rate of 10%, matures September 2018, net amortized discount of $9,479 as of September 30, 2017. 521 - $5,000 face value, issued in September 2017, interest rate of 0%, matures March 2018, net amortized discount of $4,752 as of September 30, 2017. 247 - $50,000 face value, issued in September 2017, interest rate of 0%, matures November 2017, net amortized discount of $42,633 as of September 30, 2017. 7,367 - Total convertible notes payable – non-related parties 2,470,073 2,267,845 Less current portion 2,470,073 2,267,845 Convertible notes payable – non-related parties, long-term $ - $ - On November 20, 2015, the Company issued a convertible note to an unrelated company for $600,000 that matures on May 20, 2016. The company paid $200,000 in principle balance leaving a remain balance of $430,000 including the extension fees and is not convertible unless the borrower defaults under the amendment agreement dated January 1, 2017. The note bears 0% interest and had an original issue discount (OID) of $100,000. This note is not convertible unless there is a default event, so no BCF was valued. The Company extended the maturity date for the sixth time by issuing additional $30,000 convertible notes on January 1, 2017 to February 15, 2017 and per the terms of the note there are no derivatives until it becomes convertible on the original note, however the $30,000 addition for the extension is to be considered derivatives. The Lender released a clarification of amendments to convertible promissory notes that explained the $30,000 extension fees are the only portion that is to be considered as convertible and converts within 2 days of issuance. The intent of the amendment agreements were to insure the original note dated November 20, 2015 in the amount of $600,000. Due to the conversion into 145,929 shares of common stock on January 1, 2017 (extension date) and January 3, 2017 (conversion date) sequencing is required on other instruments. Because the terms do not dictate a maximum numbers of convertible shares, the ability to settle these obligations with shares would be unavailable causing these obligations to potentially be settled in cash. This condition creates a derivative liability Under ASC 815-40. The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares. During the extension and conversion day period no additional convertible instruments were issued, therefore on the extension was considered in the derivative calculation. The Company extended the maturity date for the seventh time by increasing the principal balance by $30,000 on February 27, 2017 to May 6, 2017. The Company evaluated amendment under ASC 470-50, “ Debt - Modification and Extinguishment” Debt - Modification and Extinguishment” Debt - Modification and Extinguishment” Debt - Modification and Extinguishment” Debt - Modification and Extinguishment” On February 15, 2016, the Company issued a convertible note to an unrelated individual for $25,000 that matures on February 15, 2017. The note was amended subsequently in September 28, 2017 to extend the maturity date to October 15, 2017. The Company evaluated amendment under ASC 470-50, “ Debt - Modification and Extinguishment” On February 23, 2017, the Company issued a convertible note to an unrelated company for $149,000 that matures on November 23, 2017. The note bears 10% interest per annum and is convertible into shares of the Company’s common stock at lesser of 40% of the average three lowest closing bids 20 days prior to the conversion date. Additionally, the note contains a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. The Company determined under ASC 815, that this percentage discount (variable) exercise price indicates is an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. The Company extended the possibility to convert date by issuing 60,000 warrants valued at $7,813 on September 8, 2017 to November 2, 2017. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the . Debt - Modification and Extinguishment” On February 23, 2017, the Company issued a convertible note to an unrelated company for $224,000 that matures on November 23, 2017. The note bears 10% interest per annum and is convertible into shares of the Company’s common stock at lesser of 40% of the average three lowest closing bids 20 days prior to the conversion date. Additionally, the note contains a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. The Company determined under ASC 815, the Company has determined that this percentage discount (variable) exercise price indicates an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. The Company extended the possibility to convert date by issuing 90,000 warrants valued at $11,720 on September 8, 2017 to November 2, 2017. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the . Debt - Modification and Extinguishment” On August 26, 2016, the Company issued a convertible note to an unrelated individual for $50,000 that matures on August 26, 2017. The note bears interest rate of 10% per annum and is convertible into shares of the Company’s Common stock at $0.40 per share. The note was amended on June 30, 2017 to extend the maturity date to October 1, 2017. The Company evaluated amendment under ASC 470-50, “ Debt - Modification and Extinguishment” Debt - Modification and Extinguishment” On March 7, 2016, the Company issued a convertible note to an unrelated individual for $100,000 that matures on March 7, 2017. The note bears interest rate of 10% per annum and is convertible into shares of the Company’s Common stock at $0.40 per share. The Company valued a BCF related to the note valued at $24,269 and debt discount related to the 10,000 shares of common stock issued with the note at a relative fair value of $4,569. The note was amended again on September 28, 2017 to extend the maturity date to January 15, 2018, as additional consideration the Company issued 25,000 shares of common stock valued at $3,998. The Company evaluated amendment under ASC 470-50, “ Debt - Modification and Extinguishment” On July 26, 2016, the Company issued a convertible note to an unrelated individual for $50,000 that matures on September 26, 2016. The note bears interest rate of 0% per annum and is convertible into shares of the Company’s Common stock at $0.40 per share, as part of the note the company issued warrants to purchase 35,000 shares of 144 restricted common stock at an exercise price $0.30 for a two-year period. The note was amended on September 28, 2017 to extend the maturity date to January 15, 2018, as additional consideration the Company issued 15,000 shares of common stock valued at $2,399. The Company evaluated amendment under ASC 470-50, “ Debt - Modification and Extinguishment” On July 31, 2017, the Company issued a convertible note to an unrelated company for $78,000, which included $75,000 in proceeds and $3,000 in legal fees, that matures on April 10, 2018. The note bears 12% interest per annum and is convertible into shares of the Company’s common stock at 61% of the lowest two trading prices during the fifteen (15) trading day period ending to the date of conversion. The note contains a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. The Company determined under ASC 815, the Company has determined that this percentage discount (variable) exercise price indicates an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. On August 2, 2017, the Company issued a convertible note to an unrelated party for $50,000 that matures on August 24, 2017. The note bears 0% interest per annum, in lieu of interest the Company issued 12,000 shares of common stock on August 4, 2017. The note is convertible into shares of the Company’s common stock at $0.10 per share. Due to sequencing on February 2, 2017, the Company determined under ASC 815, the Company has determined that the note is to be treated as an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value . The note was amended on September 15, 2017, to extend the maturity date to October 15, 2017. The Company evaluated amendment under ASC 470-50, “ Debt - Modification and Extinguishment” On August 2, 2017, the Company issued a convertible note to an unrelated company for $60,500, which includes proceeds of $55,000, and $5,500 in OID, that matures on August 2, 2018. The note bears 12% interest per annum and is convertible into shares of the Company’s common stock at 61% of the lowest two trading prices during the fifteen (15) trading day period ending to the date of conversion. The note contains a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. The Company determined under ASC 815, the Company has determined that this percentage discount (variable) exercise price indicates an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. On August 4, 2017, the Company issued a convertible note to an unrelated party for $10,000 that matures on August 4, 2018. The note bears 0% interest per annum, in lieu of interest the Company issued 3,500 shares of common stock on August 7, 2017. The note is convertible into shares of the Company’s common stock at $0.10 per share. Due to sequencing on February 2, 2017, the Company determined under ASC 815, the Company has determined that the note is to be treated as an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value . On August 15, 2017, the Company issued a convertible note to an unrelated company for $82,250, which included $75,000 in proceeds and $7,250 in legal and other fees, that matures on April 18, 2018. The note bears 12% interest per annum and is convertible into shares of the Company’s common stock at 60% the lowest trading price during the previous twenty (2) days to the date of conversion. The note contains a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. The Company determined under ASC 815, the Company has determined that this percentage discount (variable) exercise price indicates an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. On August 16, 2017, the Company issued a convertible note to an unrelated company for $53,000, which included $50,000 in proceeds and $3,000 in legal fees, that matures on June 16, 2018. The note bears 12% interest per annum and is convertible into shares of the Company’s common stock at 61% of the lowest two trading prices during the fifteen (15) trading day period ending to the date of conversion. The note contains a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. The Company determined under ASC 815, the Company has determined that this percentage discount (variable) exercise price indicates an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. On September 8, 2017, the Company issued a convertible note to an unrelated company for $65,000, which included $58,500 in proceeds and $6,500 in OID, that matures on March 8, 2018. The note bears 12% interest per annum and is convertible into shares of the Company’s common stock at 55% of either the lowest sales price for common stock on principal market during the twenty-five consecutive trading days including the immediately preceding the conversion date. The note contains a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. The Company determined under ASC 815, the Company has determined that this percentage discount (variable) exercise price indicates an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. On September 11, 2017, the Company issued a convertible note to an unrelated party for $10,000 that matures on September 11, 2018. The note bears 10% interest per annum. The note is convertible into shares of the Company’s common stock at $0.10 per share. Due to sequencing on February 2, 2017, the Company determined under ASC 815, the Company has determined that the note is to be treated as an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value . On September 27, 2017, the Company issued a convertible note to an unrelated party for $5,000 that matures on March 31, 2018. The note bears 0% interest per annum. The note is convertible into shares of the Company’s common stock at $0.10 per share. Due to sequencing on February 2, 2017, the Company determined under ASC 815, the Company has determined that the note is to be treated as an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value . On September 28, 2017, the Company issued a convertible note to an unrelated party for $50,000 that matures on November 28, 2017. The note bears 0% interest per annum. The note is convertible into shares of the Company’s common stock at $0.10 per share. Due to sequencing on February 2, 2017, the Company determined under ASC 815, the Company has determined that the note is to be treated as an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value . Notes Payable – Related Parties Notes payable due to related parties consisted of the following as of September 30, 2017 and June 30, 2017, respectively: Notes Payable – Related Parties September 30, June 30, 2017 2017 Various term notes with total face value of $627,500 issued from April 11 to June 17, interest rates range from 0% to 15%, net of unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively, of which $45,000 has been paid. $ 600,000 $ 610,000 $18,000 face value, issued in September 2017, interest rate of 0%, matures November 2017. 18,000 - Total notes payable – related parties 618,000 610,000 Less current portion 618,000 610,000 Notes payable - related parties, long term $ - $ - On September 28, 2017, the Company issued a note to an unrelated party for $18,000 that matures on November 28, 2017. The note bears 0% interest per annum. Notes Payable – Non-Related Parties Notes payable due to non-related parties consisted of the following as of September 30, 2017 and June 30, 2017, respectively: Notes Payable – Non-Related Parties September 30, June 30, 2017 2017 Various term notes with total face value of $40,488 due upon demand, interest rates range from 0% to 14%. $ 40,488 $ 40,488 $52,000 face value, issued in August 2017, interest rate of 0%, matures October 2017 net of unamortized discount of $7,227 as of September 30, 2017. 44,773 - $52,000 face value, issued in August 2017, interest rate of 0%, matures October 2017 net of unamortized discount of $7,604 as of September 30, 2017. 44,396 - $81,000 face value, issued in September 2017, interest rate of 8% per month, matures March 2018 net of unamortized discount of $14,913 as of September 30, 2017. 66,087 - Total note payable – non-related parties 195,744 40,488 Less current portion 195,744 40,488 Notes payable – non-related parties, long-term $ - $ - On August 25, 2017, the Company issued a note to an unrelated party for $52,000 as part of an Accounts Receivable Financing Agreement, which included $50,000 in proceeds and an OID of $2,000, that matures on October 25, 2017. The note bears 0% interest per annum. As additional consideration the Company also issued 50,000 warrants valued at $6,625. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the . On August 31, 2017, the Company issued a note to an unrelated party for $52,000 as part of an Accounts Receivable Financing Agreement, which included $50,000 in proceeds and an OID of $2,000, that matures on October 31, 2017. The note bears 0% interest per annum. As additional consideration the Company also issued 50,000 warrants valued at $6,773. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the . On September 19, 2017, the Company issued a note to an unrelated party for $81,000 which included $74,504 in proceeds, $6,000 in OID, and $496 in other fees, that matures on March 19, 2018. The note bears 8% interest per month. As additional consideration the Company is to issue 75,000 shares of common stock within 10 days.

6. CONVERTIBLE PREFERRED STOCK

6. CONVERTIBLE PREFERRED STOCK	3 Months Ended
	Sep. 30, 2017
Equity [Abstract]
6. CONVERTIBLE PREFERRED STOCK	The Company has authorized 10,000,000 shares of $0.001 par value per share Preferred Stock, of which the following were issued outstanding: Shares Shares Liquidation Allocated Outstanding Preference Series A Convertible Preferred 100,000 15,500 - Series A-1 Convertible Preferred 3,000,000 2,585,000 3,581,964 Series B Convertible Preferred 200,000 3,500 35,000 Series C Convertible Preferred 1,000,000 13,404 - Series D Convertible P referred 375,000 130,000 - Series E Convertible Preferred 1,000,000 275,000 - Series P Convertible Preferred 600,000 86,640 - Series S Convertible Preferred 50,000 - - Total Preferred Stock 6,325,000 3,109,044 3,616,964 The Company's Series A Convertible Preferred Stock ("Series A Preferred") is convertible into Common Stock at the rate of 0.025 share of Common stock for each share of the Series A Preferred. Dividends of $0.50 per share annually from date of issue, are payable from retained earnings, but have not been declared or paid. The Company’s Series A-1 Senior Convertible Redeemable Preferred Stock (“Series A-1 Preferred”) is convertible at the rate of 2 shares of Common Stock per share of Series A-1 Preferred. The dividend rate of the Series A-1 Senior Convertible Redeemable Preferred Stock is 6% per share per annum in cash, or commencing on June 30, 2009 in shares of the Company’s Common Stock (at the option of the Company). Due to the fact that the Series A-1 Preferred has certain features of debt and is redeemable, the Company analyzed the Series A-1 Preferred in accordance with ASC 480 and ASC 815 to determine if classification within permanent equity was appropriate. Based on the fact that the redeemable nature of the stock and all cash payments are at the option of the Company, it is assumed that payments will be made in shares of the Company’s Common Stock and therefore, the instruments are afforded permanent equity treatment. The Company's Series B Convertible 8% Preferred Stock ("Series B Preferred") is convertible at the rate of 0.067 share of Common Stock for each share of Series B Preferred. Dividends from date of issue are payable on June 30 from retained earnings at the rate of 8% per annum but have not been declared or paid. The Company's Series C Convertible Preferred Stock ("Series C Preferred") is convertible at a rate of 0.007 share of Common Stock per share of Series C Preferred. Holders are entitled to dividends only to the extent of the holders of the Company’s Common Stock receive dividends. The Company's Series D Convertible Preferred Stock ("Series D Preferred") is convertible at a rate of 0.034 share of Common Stock per share of Series D Preferred. Holders are entitled to a proportionate share of any dividends paid as though they were holders of the number of shares of Common Stock of the Company into which their shares of are convertible as of the record date fixed for the determination of the holders of Common Stock of the Company entitled to receive such distribution. The Company's Series E Convertible Preferred Stock ("Series E Preferred") is convertible at a rate of 0.034 share of Common Stock per share of Series E Preferred. Holders are entitled to a proportionate share of any dividends paid as though they were holders of the number of shares of Common Stock of the Company into which their shares of are convertible as of the record date fixed for the determination of the holders of Common Stock of the Company entitled to receive such distribution. The Company's Series P Convertible Preferred Stock ("Series P Preferred") is convertible at a rate of 0.007 share of Common Stock for each share of Series P Preferred. Holders are entitled to dividends only to the extent of the holders of the Company’s Common Stock receive dividends. In the event of a liquidation, dissolution or winding up of the affairs of the Company, holders of Series A Preferred Stock, Series P Convertible Preferred Stock, Series C Convertible Preferred Stock have no liquidation preference over holders of the Company’s Common Stock. Holders of Second Series B Preferred Stock have a liquidation preference over holders of the Company’s Common Stock and the Company’s Series A Preferred Stock. Holders of Series D Preferred Stock are entitled to receive, before any distribution is made with respect to the Company’s Common Stock, a preferential payment at a rate per each whole share of Series D Preferred Stock equal to $1.00. Holders of Series E Preferred Stock are entitled to receive, after the preferential payment in full to holders of outstanding shares of Series D Preferred Stock but before any distribution is made with respect to the Company’s Common Stock, a preferential payment at a rate per each whole share of Series E Preferred Stock equal to $1.00. Holders of Series A-1 Preferred Stock are superior in rank to the Company’s Common Stock and to all other series of Preferred Stock heretofore designated with respect to dividends and liquidation. The activity surrounding the issuances of the Preferred Stock is as follows: During the three months ended September 30, 2017 the Company did not issue shares of Series A-1 Preferred. During the fiscal year ended June 30, 2017 the Company issued 550,000 shares of Series A-1 Preferred Stock for $550,000 in cash and paid $196,853 in cash offering costs The Company had one conversion of 150,000 shares of Series A-1 Preferred Stock for 300,000 shares of Common Stock, and issued 15,682 shares of Common Stock of payment of $7,481 in accrued dividends. During the three months ended September 30, 2017 and 2016, the outstanding Preferred Stock accumulated $56,367 and $42,238 in dividends on outstanding Preferred Stock. The cumulative dividends in arrears as of September 30, 2017 were approximately $908,938.

7. COMMON STOCK

7. COMMON STOCK	3 Months Ended
	Sep. 30, 2017
Text Block [Abstract]
7. COMMON STOCK	The Company has authorized 250,000,000 shares of $0.001 par value per share Common Stock, of which 122,674,082 and 118,486,728 were issued outstanding as of September 30, 2017 and June 30, 2017, respectively. The activity surrounding the issuances of the Common Stock is as follows: For the Three Months Ended September 30, 2017 The Company issued The Company issued 340,000 shares of Common Stock for the conversion of notes and accrued interest valued at $34,000. The Company issued 120,000 shares of Common Stock as payment for services and rent valued at $22,800. The Company issued 115,500 shares of Common Stock for the incentive with convertible notes valued at $15,963. The Company issued 115,000 shares of Common Stock for the extension of two convertible notes valued at $16,897. As share-based compensation to employees and non-employees, the Company issued 591,692 shares of common stock valued at $100,589, based on the market price of the stock on the date of issuance. As interest expense on outstanding notes payable, the Company issued 1,280,162 shares of common stock valued at $217,628 based on the market price on the date of issuance. For the Three Months Ended September 30, 2016 The Company issued 552,733 shares of Common Stock for the conversion of notes and accrued interest valued at $130,022. The Company also issued 100,000 shares of Common Stock as incentive to notes valued at $33,349 and recorded $30,519 in beneficial conversion features related to new issuances of debt. The Company issued 309,965 shares of Common Stock as payment for services and rent valued at $122,136. As share-based compensation to employees and non-employees, the Company issued 271,831 shares of common stock valued at $106,014, based on the market price of the stock on the date of issuance. As interest expense on outstanding notes payable, the Company issued 524,715 shares of common stock valued at $204,639 based on the market price on the date of issuance.

8. STOCK PURCHASE OPTIONS AND W

8. STOCK PURCHASE OPTIONS AND WARRANTS	3 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
8. STOCK PURCHASE OPTIONS AND WARRANTS	The Board of Directors on June 10, 2009 approved the 2009 Long-Term Stock Incentive Plan. The purpose of the 2009 Long-term Stock Incentive Plan is to advance the interests of the Company by encouraging and enabling acquisition of a financial interest in the Company by employees and other key individuals. The 2009 Long-Term Stock Incentive Plan is intended to aid the Company in attracting and retaining key employees, to stimulate the efforts of such individuals and to strengthen their desire to remain with the Company. A maximum of 1,500,000 shares of the Company's Common Stock is reserved for issuance under stock options to be issued under the 2009 Long-Term Stock Incentive Plan. The Plan permits the grant of incentive stock options, nonstatutory stock options and restricted stock awards. The 2009 Long-Term Stock Incentive Plan is administered by the Board of Directors or, at its direction, a Compensation Committee comprised of officers of the Company. Stock Purchase Options During the three months ended September 30, 2017, the Company did not issue any stock purchase options. During the fiscal year ended June 30, 2017, the Company issued 500,000 stock purchase options. The following table summarizes the changes in options outstanding of the Company during the three months ended September 30, 2017. Date Issued Number of Options Weighted Average Exercise Price Weighted Average Grant Date Fair Value Expiration Date (yrs) Value if Exercised Balance June 30, 2017 525,000 $ 0.18 $ 0.16 4.81 $ 93,750 Granted - - - - - Exercised - - - - - Cancelled/Expired - - - - - Outstanding as of September 30, 2017 525,000 $ 0.18 $ 0.20 4.56 $ 93,750 Stock Purchase Warrants During the three months ended September 30, 2017, the Company issued warrants to purchase a total of , consisting of 75,000 warrants as part of a private placement valued at $6,019, 100,000 warrants as part of two valued at $13,398 and 550,000 warrants in conjunction with extension of three promissory notes valued at $54,491. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the During the fiscal year ended June 30, 2017, the Company issued warrants to purchase a total of . The Company issued 455,000 warrants in conjunction with four promissory notes executed in February 2017 to June 2017. The warrants were valued using the Black-Scholes pricing model under the assumptions noted below. The Company apportioned value to the warrants based on the relative fair market value of the Common Stock and warrants. The following table presents the assumptions used to estimate the fair values of the stock warrants and options granted: September 30, 2017 June 30, 2017 Expected volatility 105-174% 92-126% Expected dividends 0% 0% Expected term 0-5 Years 0-5 Years Risk-free interest rate 0.96-1.77% 0.74-1.89% The following table summarizes the changes in warrants outstanding issued to employees and non-employees of the Company during the three months ended September 30, 2017. Number of Warrants Weighted Average Exercise Price Weighted Average Grant Date Fair Value Expiration Date (yrs) Value if Exercised Outstanding as of June 30, 2017 39,927,097 $ 0.38 $ 0.45 3.38 $ 15,144,835 Granted 725,000 0.20 0.10 3.31 146,250 Exercised - - - - - Cancelled/Expired (65,000 ) 0.36 - - (40,000 ) Outstanding as of September 30, 2017 40,587,097 $ 0.38 $ 0.48 3.38 $ 15,251,085

9. FINANCIAL INSTRUMENTS

9. FINANCIAL INSTRUMENTS	3 Months Ended
	Sep. 30, 2017
Financial Instruments
9. FINANCIAL INSTRUMENTS	The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has estimated the fair value of these embedded derivatives for convertible debentures and associated warrants using a multinomial lattice model as of September 30, 2017 and June 30, 2017. The fair values of the derivative instruments are measured each quarter, which resulted in a loss of $209,039 and $111, and derivative expense of $133,652 and $0 during the three months ended September 30, 2017 and 2016, respectively. As of September 30, 2017, and June 30, 2017, the fair market value of the derivatives aggregated $2,932,616 and $2,145,065, respectively, using the following assumptions: estimated 5-0 year term, estimated volatility of 174.38 -104.82%, and a discount rate of 1.77-0.96%.

10. FAIR VALUE MEASUREMENTS

10. FAIR VALUE MEASUREMENTS	3 Months Ended
	Sep. 30, 2017
Fair Value Measurements
10. FAIR VALUE MEASUREMENTS	For asset and liabilities measured at fair value, the Company uses the following hierarchy of inputs: ● Level one — Quoted market prices in active markets for identical assets or liabilities; ● Level two — Inputs other than level one inputs that are either directly or indirectly observable; and ● Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. Liabilities measured at fair value on a recurring basis at September 30, 2017, are summarized as follows: Level 1 Level 2 Level 3 Total Fair value of derivatives $ - $ - $ 2,932,616 $ 2,932,616 Securities available-for-sale $ 47,940 $ - $ - $ 47,940

11. COMMITMENTS AND CONTINGENCI

11. COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
11. COMMITMENTS AND CONTINGENCIES	Legal Proceedings The Company may become involved in certain legal proceedings and claims which arise in the normal course of business. The Company is not a party to any litigation. To the best of the knowledge of our management, there are no material litigation matters pending or threatened against us. Lease Agreements We lease offices in Hollywood, California (located at 6671 Sunset Blvd., Suite 1520, 1518 and 1550, Hollywood, California, 90028) for corporate, research, engineering and mastering services. The lease expires on December 31, 2017. The total lease expense for the facility is approximately $17,220 per month, and the total remaining obligations under these leases at September 30, 2017, were approximately $52,722. We lease a warehouse space located at 8260 E Gelding Drive, Suite 102, Scottsdale, Arizona, 85260. The lease expires on February 28, 2019. The total lease expense for the facility is approximately $1,888 per month, and the total remaining obligations under this leases at September 30, 2017, were approximately $5,786. We lease corporate offices located at 7825 E Gelding Drive, Suite 101, Scottsdale, Arizona, 85260. The lease expires on April 30, 2021. The total lease expense for the facility is approximately $7,224 per month, and the total remaining obligations under this leases at September 30, 2017, were approximately $22,701. We lease corporate offices located at 7825 E Gelding Drive, Suite 103, Scottsdale, Arizona, 85260. The lease expires on April 30, 2021. The total lease expense for the facility is approximately $3,000 per month, and the total remaining obligations under this leases at September 30, 2017, were approximately $9,000. Below is a table summarizing the annual operating lease obligations over the next 5 years: Year Lease Payments 2018 $ 127,561 2019 141,464 2020 131,475 2021 87,287 2022 - Total $ 487,786 Other The Company has not declared dividends on Series A or B Convertible Preferred Stock or its Series A-1 Convertible Preferred Stock. The cumulative dividends in arrears through September 30, 2017 were approximately $965,305. As of the date of this filing, the Company has not filed its tax return for the fiscal year ended 2015, 2016, and 2017.

12. SUBSEQUENT EVENTS

12. SUBSEQUENT EVENTS	3 Months Ended
	Sep. 30, 2017
Subsequent Events [Abstract]
12. SUBSEQUENT EVENTS	In accordance with ASC 855, Company’s management reviewed all material events through the date of this filing and determined that there were the following material subsequent events to report: From October through November, the Company issued The Company also issued 75,000 warrants as part of a private placement valued at $6,019. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the . On October 16, 2017, the Company issued a convertible note to an unrelated company for $110,000 that matures on July 16, 2018. The note bears 10% interest per annum and is convertible into shares of the Company’s common stock at 57.5% of the lowest closing bid 30 days prior to the conversion date. Additionally, the note contains a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. The Company determined under ASC 815, the Company has determined that this percentage discount (variable) exercise price indicates that these shares, if issued, are not indexed to the Company’s own stock and, therefore, is an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. The Company extended the possibility to convert date by issuing 60,000 warrants valued at $7,813 on September 8, 2017 to November 2, 2017. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the . The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the . Debt - Modification and Extinguishment” On February 23, 2017, the Company issued a convertible note to an unrelated company for $224,000 that matures on November 23, The Company extended the possibility to convert date by issuing 90,000 warrants valued at $11,720 on September 8, 2017 to November 2, 2017. The Company extended the possibility to convert date by paying $251,726 in principal on October 23, 2017 to February 21, 2018. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the . Debt - Modification and Extinguishment” On October 29, 2017, the Company issued a convertible note to an unrelated company for $100,000 that matures on October 29, 2018. The note bears 10% interest per annum and is convertible into shares of the Company’s common stock at $.10. The Company determined under ASC 815, the Company has determined that this percentage discount (variable) exercise price indicates that these shares, if issued, are not indexed to the Company’s own stock and, therefore, is an embedded derivative financial liability, which requires bifurcation and to be separately accounted for. At each reporting period, the Company will mark this derivative financial instrument to its estimated fair value. On October 31, 2017, the Company issued a secured promissory note to an unrelated party for $255,000, that matures on February 28, 2018. The note bears 2.5% interest per month. The note is to be paid back the greater of $1,000 per day and $75 per unit sold commencing 31 days after closing, the greater of $1,500 per day and $75 per unit sold commencing 61 days after closing, the greater of $2,000 per day and $75 per unit sold commencing 91 days after closing. The note was amended on October 30, 2017, to extend the conversion rights from 180 days to 225 days, in consideration of the extension the Company paid $25,000 and issued 150,000 valued at $6,691. The Company evaluated amendment under ASC 470-50, “ Debt - Modification and Extinguishment” On November 1, 2017, the Company issued warrants to purchase a total of in conjunction with extension of three promissory notes valued at $6,691. The warrants are considered derivative liabilities under ASC 815-40 under the Company’s sequencing policy and were valued using the The Company extended the maturity date for the tenth time by paying additional consideration of $30,000 on August 3, 2017 to September 18, 2017. The Company evaluated amendment under ASC 470-50, “ Debt - Modification and Extinguishment” Debt - Modification and Extinguishment” Debt - Modification and Extinguishment”

3. SUMMARY OF SIGNIFICANT ACC18

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Use of Estimates	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates are made in relation to the allowance for doubtful accounts and the fair value of certain financial instruments.
Principles of Consolidation	The consolidated financial statements include the accounts of AfterMaster, Inc. and its subsidiaries. All significant inter-Company accounts and transactions have been eliminated.
Investments	Our available for securities are considered Level 1. Realized gains and losses on these securities are included in “Other income (expense) – net” in the consolidated statements of operations using the specific identification method. Unrealized gains and losses, on available-for-sale securities are recorded in accumulated other comprehensive income (accumulated OCI). Unrealized losses that are considered other than temporary are recorded in other income (expense) – net, with the corresponding reduction to the carrying basis of the investment. Our short-term investments are recorded at amortized cost, and the respective carrying amounts approximate fair values. Our available for securities maturing within one year are recorded in “Other current assets,” on the balance sheets.
Accounts Receivables	Accounts receivables are stated at amounts management expects to collect. An allowance for doubtful accounts is provided for uncollectible receivables based upon management's evaluation of outstanding accounts receivable at each reporting period considering historical experience and customer credit quality and delinquency status. Delinquency status is determined by contractual terms. Bad debts are written off against the allowance when identified.
Fair Value Instruments	Cash is the Company’s only financial asset or liability required to be recognized at fair value and is measured using quoted prices for active markets for identical assets (Level 1 fair value hierarchy). The carrying amounts reported in the balance sheets for notes receivable and accounts payable and accrued expenses approximate their fair market value based on the short-term maturity of these instruments. Market prices are not available for the Company’s loans due to related parties or its other notes payable, nor are market prices of similar loans available. The Company determined that the fair value of the notes payable based on its amortized cost basis due to the short-term nature and current borrowing terms available to the Company for these instruments.
Derivative Liabilities	The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares. Using this sequencing policy, the Company used this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to July 5, 2016 until the note was converted on the same day were derivative liabilities. The Company again used this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to August 19, 2016 until the note was converted on August 22, 2016 were derivative liabilities. The Company entered into multiple amendments to a note payable to extend the maturity date (the Amendments). The Company agreed to additional $30,000 extension fees which were converted at a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. This creates a situation where the Company no longer has shares enough available to “cover” all potential equity issuance obligations during the period of issuance until conversion. On February 3, 2017, the company entered into a note payable with an unrelated party at a percentage discount (variable) exercise price which causes the number to be converted into a number of common shares that “approach infinity”, as the underlying stock price could approach zero. Accordingly, all convertible instruments issued after February 3, 2017 are considered derivatives according to the Company’s sequencing policy. The Company values these convertible notes payable using the multinomial lattice method that values the derivative liability within the notes based on a probability weighted discounted cash flow model. The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the statement of operations.
Income Taxes	There is no income tax provision for the three months ended September 30, 2017 and 2016 due to net operating losses for which there is no benefit currently available. At September 30, 2017, the Company had deferred tax assets associated with state and federal net operating losses. The Company has recorded a corresponding full valuation allowance as it is more likely than not that some portion of all of the deferred tax assets will not be realized.
Revenue Recognition	The Company applies the provisions of FASB ASC 605, Revenue Recognition in Financial Statements The Company's revenues are generated from AfterMaster products and services, AfterMaster Pro, sessions revenue, and remastering. Revenues related to AfterMaster Pro sells through consumer retail distribution channels and through our website. For sales through consumer retail distribution channels, revenue recognition occurs when title and risk of loss have transferred to the customer which usually occurs upon shipment to the customers. We established allowances for expected product returns and these allowances are recorded as a direct reduction to revenue. Return allowances are based on our historical experience. Revenues related to sessions and remastering are recognized when the event occured.
Cost of Revenues	The Company’s cost of revenues includes employee costs, and other nominal amounts. Costs associated with products are recognized at the time of the sale and when the inventory is shipped. Costs incurred to provide services are recognized as cost of sales as incurred. Depreciation is not included within cost of revenues.
Loss Per Share	Basic loss per Common Share is computed by dividing losses attributable to Common shareholders by the weighted-average number of shares of Common Stock outstanding during the period. The losses attributable to Common shareholders was increased for accrued and deemed dividends on Preferred Stock during the three months ended September 30, 2017 and 2016 of $56,367 and $42,238, respectively. Diluted earnings per Common Share is computed by dividing net loss attributable to Common shareholders by the weighted-average number of Shares of Common Stock outstanding during the period increased to include the number of additional Shares of Common Stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding convertible Preferred Stock, stock options, warrants, and convertible debt. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s Common Stock can result in a greater dilutive effect from potentially dilutive securities. For the three months ended September 30, 2017 and 2016, all of the Company’s potentially dilutive securities (warrants, options, convertible preferred stock, and convertible debt) were excluded from the computation of diluted earnings per share as they were anti-dilutive. The total number of potentially dilutive Common Shares that were excluded were 37,364,624 and 27,689,839 at September 30, 2017 and 2016, respectively.
Recent Accounting Pronouncements	Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

4. SECURITIES AVAILABLE-FOR-S19

4. SECURITIES AVAILABLE-FOR-SALE (Tables)	3 Months Ended
	Sep. 30, 2017
Securities Available-for-sale Tables
Securities Available-for-Sale	September 30, 2017 Amortized cost Gross unrealized gains Gross unrealized losses Gross realized gains Gross realized losses Fair value Equity securities $ 123,600 $ (75,660 ) $ - $ - $ - $ 47,940 June 30, 2017 Amortized cost Gross unrealized gains Gross unrealized losses Gross realized gains Gross realized losses Fair value Equity securities $ 63,600 $ 60,000 $ - $ - $ - $ 123,600

5. NOTES PAYABLE (Tables)

5. NOTES PAYABLE (Tables)	3 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Schedule of Convertible Notes Payable-Related Parties	Convertible Notes Payable – Related Parties September 30, June 30, 2017 2017 Various term notes with total face value of $3,925,000 issued from February 2010 to April 2013, interest rates range from 10% to 15%, net of unamortized discount of $0 as of September 30, 2017 and June 30, 2017. $ 3,925,000 $ 3,925,000 $30,000 face value, issued in August 2016, interest rate of 0%, matures January 2017, a gain on extinguishment of debt was recorded totaling $3,818 net unamortized discount of $0 as of September 30, 2017 and June 30, 2017. 30,000 26,182 Total convertible notes payable – related parties 3,955,000 3,951,182 Less current portion 3,955,000 3,951,182 Convertible notes payable – related parties, long-term $ - $ -
Schedule of Convertible Notes Payable-Non-Related Parties	Convertible Notes Payable - Non-Related Parties September 30, June 30, 2017 2017 $7,000 face value, issued in July 2014, interest rate of 6%, matures October 2017, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. $ 7,000 $ 7,000 $600,000 face value, issued in November 2015, interest rate of 0%, an OID of $190,000, matures November 2017, net unamortized discount of $0 of J September 30, 2017 and June 30, 2017, respectively, of which $260,000 has been paid. 430,000 430,000 $100,000 face value, issued in February 2016, interest rate of 10%, matures March 2018, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. 100,000 100,000 $25,000 face value, issued in February 2016, interest rate of 10%, matures February 2017, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. 25,000 25,000 $100,000 face value, issued in March 2016, interest rate of 10%, matures June2017, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. 100,000 100,000 $10,000 face value, issued in March 2016, interest rate of 10%, matures March 2018, net unamortized discount $0 of September 30, 2017 and June 30, 2017, respectively. 10,000 10,000 $50,000 face value, issued in July 2016, interest rate of 0%, matures October 2017, net unamortized discount of $0 of September 30, 2017 and June 30, 2017, respectively. 50,000 50,000 $50,000 face value, issued in August 2016, interest rate of 0%, matures September which was amended to January 2018, net unamortized discount of $44,308 and $5,418 of September 30, 2017 and June 30, 2017, respectively. 5,692 44,582 $1,000,000 face value, issued in September 2016, interest rate of 10%, matures June 2017, net unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively. 1,000,000 1,000,000 $149,000 face value, issued in February 2017, interest rate of 10%, matures November 2017, net amortized discount of $0 and $59,740 as of September 30, 2017 and June 30, 2017, respectively, of which $20,000 has been paid. 129,000 89,260 $224,000 face value, issued in February 2017, interest rate of 10%, matures November 2017, net amortized discount of $32,452 and $119,795 as of September 30, 2017 and June 30, 2017, respectively, of which $15,000 has been paid. 176,548 104,205 $258,000 face value, issued in February 2017, interest rate of 12%, matures August 2017, net amortized discount of $0 and $48,464 as of September 30, 2017 and June 30, 2017, respectively, of which $185,000 has been paid. 133,000 209,536 $55,000 face value, issued in June 2017, interest rate of 10%, matures January 2018, net amortized discount of $26,986 and $50,631 as of September 30, 2017 and June 30, 2017, respectively. 28,014 4,369 $100,000 face value, issued in June 2017, interest rate of 7%, matures June 2018, net amortized discount of $39,130 and $52,317 as of September 30, 2017 and June 30, 2017, respectively. 60,870 47,683 $265,000 face value, issued in May 2017, interest rate of 10%, matures February 2018, net amortized discount of $132,028 and $218,790 as of September 30, 2017 and June 30, 2017, respectively. 132,972 46,210 $78,000 face value, issued in July 2017, interest rate of 12%, matures May 2018, net amortized discount of $61,187 as of September 30, 2017. 16,813 - $50,000 face value, issued in August 2017, interest rate of 0%, matures October 2017, net amortized discount of $0 as of September 30, 2017, of which $34,000 has been converted. 16,000 - $60,500 face value, issued in August 2017, interest rate of 12%, matures August 2018, net amortized discount of $50,721 as of September 30, 2017. 9,779 - $10,000 face value, issued in August 2017, interest rate of 0%, matures August 2018, net amortized discount of $8,204 as of September 30, 2017. 1,796 - $82,250 face value, issued in August 2017, interest rate of 12%, matures May 2018, net amortized discount of $68,542 as of September 30, 2017. 13,708 - $53,000 face value, issued in August 2017, interest rate of 12%, matures June 2018, net amortized discount of $45,155 as of September 30, 2017. 7,845 - $65,000 face value, issued in September 2017, interest rate of 12%, matures March 2018, net amortized discount of $57,099 as of September 30, 2017. 7,901 - $10,000 face value, issued in September 2017, interest rate of 10%, matures September 2018, net amortized discount of $9,479 as of September 30, 2017. 521 - $5,000 face value, issued in September 2017, interest rate of 0%, matures March 2018, net amortized discount of $4,752 as of September 30, 2017. 247 - $50,000 face value, issued in September 2017, interest rate of 0%, matures November 2017, net amortized discount of $42,633 as of September 30, 2017. 7,367 - Total convertible notes payable – non-related parties 2,470,073 2,267,845 Less current portion 2,470,073 2,267,845 Convertible notes payable – non-related parties, long-term $ - $ -
Schedule of Non-Convertible Notes Payable-Related Parties	Notes Payable – Related Parties September 30, June 30, 2017 2017 Various term notes with total face value of $627,500 issued from April 11 to June 17, interest rates range from 0% to 15%, net of unamortized discount of $0 as of September 30, 2017 and June 30, 2017, respectively, of which $45,000 has been paid. $ 600,000 $ 610,000 $18,000 face value, issued in September 2017, interest rate of 0%, matures November 2017. 18,000 - Total notes payable – related parties 618,000 610,000 Less current portion 618,000 610,000 Notes payable - related parties, long term $ - $ -
Schedule of Non-Convertible Notes Payable-Non-Related Parties	Notes Payable – Non-Related Parties September 30, June 30, 2017 2017 Various term notes with total face value of $40,488 due upon demand, interest rates range from 0% to 14%. $ 40,488 $ 40,488 $52,000 face value, issued in August 2017, interest rate of 0%, matures October 2017 net of unamortized discount of $7,227 as of September 30, 2017. 44,773 - $52,000 face value, issued in August 2017, interest rate of 0%, matures October 2017 net of unamortized discount of $7,604 as of September 30, 2017. 44,396 - $81,000 face value, issued in September 2017, interest rate of 8% per month, matures March 2018 net of unamortized discount of $14,913 as of September 30, 2017. 66,087 - Total note payable – non-related parties 195,744 40,488 Less current portion 195,744 40,488 Notes payable – non-related parties, long-term $ - $ -

6. CONVERTIBLE PREFERRED STOCK

6. CONVERTIBLE PREFERRED STOCK (Tables)	3 Months Ended
	Sep. 30, 2017
Convertible Preferred Stock Tables
Schedule of Preferred Stock	Shares Shares Liquidation Allocated Outstanding Preference Series A Convertible Preferred 100,000 15,500 - Series A-1 Convertible Preferred 3,000,000 2,585,000 3,581,964 Series B Convertible Preferred 200,000 3,500 35,000 Series C Convertible Preferred 1,000,000 13,404 - Series D Convertible P referred 375,000 130,000 - Series E Convertible Preferred 1,000,000 275,000 - Series P Convertible Preferred 600,000 86,640 - Series S Convertible Preferred 50,000 - - Total Preferred Stock 6,325,000 3,109,044 3,616,964

8. STOCK PURCHASE OPTIONS AND22

8. STOCK PURCHASE OPTIONS AND WARRANTS (Tables)	3 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Schedule of options activity	Date Issued Number of Options Weighted Average Exercise Price Weighted Average Grant Date Fair Value Expiration Date (yrs) Value if Exercised Balance June 30, 2017 525,000 $ 0.18 $ 0.16 4.81 $ 93,750 Granted - - - - - Exercised - - - - - Cancelled/Expired - - - - - Outstanding as of September 30, 2017 525,000 $ 0.18 $ 0.20 4.56 $ 93,750
Schedule of Assumptions Used to Estimate Fair Value	September 30, 2017 June 30, 2017 Expected volatility 105-174% 92-126% Expected dividends 0% 0% Expected term 0-5 Years 0-5 Years Risk-free interest rate 0.96-1.77% 0.74-1.89%
Schedule of Warrants	Number of Warrants Weighted Average Exercise Price Weighted Average Grant Date Fair Value Expiration Date (yrs) Value if Exercised Outstanding as of June 30, 2017 39,927,097 $ 0.38 $ 0.45 3.38 $ 15,144,835 Granted 725,000 0.20 0.10 3.31 146,250 Exercised - - - - - Cancelled/Expired (65,000 ) 0.36 - - (40,000 ) Outstanding as of September 30, 2017 40,587,097 $ 0.38 $ 0.48 3.38 $ 15,251,085

10. FAIR VALUE MEASUREMENTS (Ta

10. FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Sep. 30, 2017
Fair Value Measurements Tables
Schedule or fair value measurements	Level 1 Level 2 Level 3 Total Fair value of derivatives $ - $ - $ 2,932,616 $ 2,932,616 Securities available-for-sale $ 47,940 $ - $ - $ 47,940

11. COMMITMENTS AND CONTINGEN24

11. COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Annual operating lease obligations	Year Lease Payments 2018 $ 127,561 2019 141,464 2020 131,475 2021 87,287 2022 - Total $ 487,786

3. SUMMARY OF SIGNIFICANT ACC25

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Summary Of Significant Accounting Policies Details Narrative
Preferred Stock Accretion and Dividends	$ (56,367)	$ (42,238)
Potentially dilutive common shares excluded	37,364,624	27,689,839

4. SECURITIES AVAILABLE-FOR-S26

4. SECURITIES AVAILABLE-FOR-SALE (Details) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017
Fair value	$ 47,940
Securities Available-for-sale
Amortized cost	123,600	$ 63,600
Gross unrealized gains	(75,660)	60,000
Gross unrealized losses	0	0
Gross realized gains	0	0
Gross realized losses	0	0
Fair value	$ 47,940	$ 123,600

5. NOTES PAYABLE (Details)

5. NOTES PAYABLE (Details) - USD ($)	Sep. 30, 2017	Jun. 30, 2017
Total convertible notes payable - related parties	$ 3,955,000	$ 3,951,182
Less current portion	3,955,000	3,951,182
Convertible related party notes payable, net of current portion	0	0
Convertible Notes Payable One [Member]
Total convertible notes payable - related parties	3,925,000	3,925,000
Convertible Notes Payable Two [Member]
Total convertible notes payable - related parties	$ 30,000	$ 26,182

5. NOTES PAYABLE (Details 1)

5. NOTES PAYABLE (Details 1) - USD ($)	Sep. 30, 2017	Jun. 30, 2017	Sep. 30, 2016
Less current portion	$ 2,470,073	$ 2,267,845	$ 2,470,073
Convertible notes payable - non-related parties, long-term		0	$ 0
Convertible Notes Payable One [Member]
Total convertible notes payable - non-related parties	7,000	7,000
Convertible Notes Payable Two [Member]
Total convertible notes payable - non-related parties	430,000	430,000
Convertible Notes Payable Three [Member]
Total convertible notes payable - non-related parties	100,000	100,000
Convertible Notes Payable Four [Member]
Total convertible notes payable - non-related parties	25,000	25,000
Convertible Notes Payable Five [Member]
Total convertible notes payable - non-related parties	100,000	100,000
Convertible Notes Payable Six [Member]
Total convertible notes payable - non-related parties	10,000	10,000
Convertible Notes Payable Seven [Member]
Total convertible notes payable - non-related parties	50,000	50,000
Convertible Notes Payable Eight [Member]
Total convertible notes payable - non-related parties	5,692	44,582
Convertible Notes Payable Nine [Member]
Total convertible notes payable - non-related parties	1,000,000	1,000,000
Convertible Notes Payable Ten [Member]
Total convertible notes payable - non-related parties	129,000	89,260
Convertible Notes Payable Eleven [Member]
Total convertible notes payable - non-related parties	176,548	104,205
Convertible Notes Payable Twelve [Member]
Total convertible notes payable - non-related parties	133,000	209,536
Convertible Notes Payable Thirteen [Member]
Total convertible notes payable - non-related parties	28,014	4,369
Convertible Notes Payable Fourteen [Member]
Total convertible notes payable - non-related parties	60,870	47,683
Convertible Notes Payable Fifteen [Member]
Total convertible notes payable - non-related parties	132,972	46,210
Convertible Notes Payable Sixteen [Member]
Total convertible notes payable - non-related parties	16,813	0
Convertible Notes Payable Seventeen [Member]
Total convertible notes payable - non-related parties	16,000	0
Convertible Notes Payable Eighteen [Member]
Total convertible notes payable - non-related parties	9,779	0
Convertible Notes Payable Nineteen [Member]
Total convertible notes payable - non-related parties	1,796	0
Convertible Notes Payable Twenty [Member]
Total convertible notes payable - non-related parties	13,708	0
Convertible Notes Payable Twenty One [Member]
Total convertible notes payable - non-related parties	7,845	0
Convertible Notes Payable Twenty Two [Member]
Total convertible notes payable - non-related parties	7,901	0
Convertible Notes Payable Twenty Three [Member]
Total convertible notes payable - non-related parties	521	0
Convertible Notes Payable Twenty Four [Member]
Total convertible notes payable - non-related parties	247	0
Convertible Notes Payable Twenty Five [Member]
Total convertible notes payable - non-related parties	7,367	0
Convertible Notes Payable [Member]
Total convertible notes payable - non-related parties	$ 2,470,073	$ 2,267,845

5. NOTES PAYABLE (Details 2)

5. NOTES PAYABLE (Details 2) - USD ($)	Sep. 30, 2017	Jun. 30, 2017
Notes payable - related parties	$ 618,000	$ 610,000
Less current portion	618,000	610,000
Notes payable - related parties, long term	0	0
Convertible Notes Payable One [Member]
Notes payable - related parties	600,000	610,000
Convertible Notes Payable Two [Member]
Notes payable - related parties	$ 18,000	$ 0

5. NOTES PAYABLE (Details 3)

5. NOTES PAYABLE (Details 3) - USD ($)	Sep. 30, 2017	Jun. 30, 2017
Note payable - non-related parties	$ 195,744	$ 40,488
Less current portion	195,744	40,488
Notes payable - non-related parties, long-term	0	0
Convertible Notes Payable One [Member]
Note payable - non-related parties	40,488	40,488
Convertible Notes Payable Two [Member]
Note payable - non-related parties	44,773	0
Convertible Notes Payable Three [Member]
Note payable - non-related parties	44,396	0
Convertible Notes Payable Four [Member]
Note payable - non-related parties	$ 66,087	$ 0

6. CONVERTIBLE PREFERRED STOC31

6. CONVERTIBLE PREFERRED STOCK (Details)	Sep. 30, 2017shares
Shares Allocated
Series A Convertible Preferred	100,000
Series A-1 Convertible Preferred	3,000,000
Series B Convertible Preferred	200,000
Series C Convertible Preferred	1,000,000
Series D Convertible Preferred	375,000
Series E Convertible Preferred	1,000,000
Series P Convertible Preferred	600,000
Series S Convertible Preferred	50,000
Total Preferred Stock	6,325,000
Shares Outstanding
Series A Convertible Preferred	15,500
Series A-1 Convertible Preferred	2,585,000
Series B Convertible Preferred	3,500
Series C Convertible Preferred	13,404
Series D Convertible Preferred	130,000
Series E Convertible Preferred	275,000
Series P Convertible Preferred	86,640
Series S Convertible Preferred	0
Total Preferred Stock	3,109,044
Liquidation Preference
Series A Convertible Preferred	0
Series A-1 Convertible Preferred	3,581,964
Series B Convertible Preferred	35,000
Series C Convertible Preferred	0
Series D Convertible Preferred	0
Series E Convertible Preferred	0
Series P Convertible Preferred	0
Series S Convertible Preferred	0
Total Preferred Stock	3,616,964

6. CONVERTIBLE PREFERRED STOC32

6. CONVERTIBLE PREFERRED STOCK (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Equity [Abstract]
Dividends on preferred stock	$ 56,367	$ 42,238
Dividends in arrears	$ 908,938

7. COMMON STOCK (Details Narrat

7. COMMON STOCK (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017
Text Block [Abstract]
Common stock, par value	$ 0.001		$ 0.001
Common stock, authorized shares	250,000,000		250,000,000
Common stock, issued shares	122,674,082		118,486,728
Common stock, outstanding shares	122,674,082		118,486,728
Common shares issue for cash, shares	1,625,000
Common shares issue for cash, value	$ 168,500
Common stock issued for conversion of notes and accrued interest, shares	340,000	552,733
Common stock issued for conversion of notes and accrued interest, value	$ 34,000	$ 130,022
Common stock issued for services and rent, shares	120,000	309,965
Common stock issued for services and rent value	$ 228,800	$ 122,136
Common stock issued for convertible note, shares	115,500
Common stock issued for convertible note, value	$ 15,963
Common stock issued for the extension of convertible note, shares	115,000
Common stock issued for the extension of convertible note, value	$ 16,897
Share based compensation to employees and non-employees, shares	591,692	271,831
Share based compensation to employees and non-employees, value	$ 100,589	$ 106,014
Common stock issued for interest expense on outstanding notes payable, shares	1,280,162	524,715
Common stock issued for interest expense on outstanding notes payable, value	$ 217,628	$ 204,639
Common stock issued as incentive to notes, shares		100,000
Common stock issued as incentive to notes, value		$ 33,349

8. STOCK PURCHASE OPTIONS AND34

8. STOCK PURCHASE OPTIONS AND WARRANTS (Details)	3 Months Ended
	Sep. 30, 2017USD ($)$ / sharesshares
Stock Purchase Options And Warrants Details 2
Number of Options/Warrants Outstanding | shares	525,000
Number of Warrants Granted | shares	0
Number of Warrants Exercised | shares	0
Number of Warrants Canceled/Expired | shares	0
Number of Options/Warrants Outstanding | shares	525,000
Weighted Average Exercise Price Outstanding, Beginning	$ .18
Weighted Average Exercise Price Granted	0
Weighted Average Exercise Price Exercised	0
Weighted Average Exercise Price Canceled/Expired	.00
Weighted Average Exercise Price Outstanding, Ending	.18
Weighted Average Grant Date Fair Value Outstanding beginning	.16
Weighted Average Grant Date Fair Value Outstanding, granted	0
Weighted Average Grant Date Fair Value Outstanding, exercised	0
Weighted Average Grant Date Fair Value Outstanding, cancelled	0
Weighted Average Grant Date Fair Value Outstanding, ending	$ .20
Expiration Date outstanding, beginning	4 years 9 months 22 days
Expiration Date outstanding, ending	4 years 6 months 22 days
Value if Exercised, Beginning | $	$ 93,750
Value if Exercised, Granted | $	0
Value if Exercised | $	0
Value if Exercised, Cancelled | $	0
Value if Exercised, Ending | $	$ 93,750

8. STOCK PURCHASE OPTIONS AND35

8. STOCK PURCHASE OPTIONS AND WARRANTS (Details 1)	3 Months Ended	12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017
Stock Purchase Options And Warrants Details 1
Expected volatility, minimum	105.00%	92.00%
Expected volatility, maximum	174.00%	126.00%
Expected dividends	0.00%	0.00%
Expected term, minimum	0 years	0 years
Expected term, maximum	5 years	5 years
Risk-free interest rate, minimum	0.96%	0.74%
Risk-free interest rate, maximum	1.77%	1.89%

8. STOCK PURCHASE OPTIONS AND36

8. STOCK PURCHASE OPTIONS AND WARRANTS (Details 2)	3 Months Ended
	Sep. 30, 2017USD ($)$ / sharesshares
Number of Options/Warrants Outstanding | shares	525,000
Number of Options/Warrants Granted | shares	0
Number of Options/Warrants Exercised | shares	0
Number of Options/Warrants Canceled/Expired | shares	0
Number of Options/Warrants Outstanding | shares	525,000
Weighted Average Exercise Price Outstanding, Beginning	$ .18
Weighted Average Exercise Price Granted	0
Weighted Average Exercise Price Exercised	0
Weighted Average Exercise Price Canceled/Expired	.00
Weighted Average Exercise Price Outstanding, Ending	.18
Weighted Average Grant Date Fair Value Outstanding beginning	.16
Weighted Average Grant Date Fair Value Outstanding, granted	0
Weighted Average Grant Date Fair Value Outstanding, exercised	0
Weighted Average Grant Date Fair Value Outstanding, cancelled	0
Weighted Average Grant Date Fair Value Outstanding, ending	$ .20
Expiration Date outstanding, beginning	4 years 9 months 22 days
Expiration Date, ending	4 years 6 months 22 days
Value if Exercised, Beginning | $	$ 93,750
Value if Exercised, Granted | $	0
Value if Exercised | $	0
Value if Exercised, Cancelled/Expired | $	0
Value if Exercised, Ending | $	$ 93,750
Stock Options
Number of Options/Warrants Outstanding | shares	39,927,097
Number of Options/Warrants Granted | shares	725,000
Number of Options/Warrants Exercised | shares	0
Number of Options/Warrants Canceled/Expired | shares	(65,000)
Number of Options/Warrants Outstanding | shares	40,587,097
Weighted Average Exercise Price Outstanding, Beginning	$ .38
Weighted Average Exercise Price Granted	.20
Weighted Average Exercise Price Exercised	0
Weighted Average Exercise Price Canceled/Expired	.36
Weighted Average Exercise Price Outstanding, Ending	.38
Weighted Average Grant Date Fair Value Outstanding beginning	.45
Weighted Average Grant Date Fair Value Outstanding, granted	.10
Weighted Average Grant Date Fair Value Outstanding, exercised	0
Weighted Average Grant Date Fair Value Outstanding, cancelled	0
Weighted Average Grant Date Fair Value Outstanding, ending	$ .48
Expiration Date outstanding, beginning	3 years 4 months 17 days
Expiration Date, granted	3 years 3 months 22 days
Expiration Date, ending	3 years 4 months 17 days
Value if Exercised, Beginning | $	$ 15,144,835
Value if Exercised, Granted | $	146,250
Value if Exercised | $	0
Value if Exercised, Cancelled/Expired | $	(40,000)
Value if Exercised, Ending | $	$ 15,251,085

8. STOCK PURCHASE OPTIONS AND37

8. STOCK PURCHASE OPTIONS AND WARRANTS (Details Narrative) - shares	3 Months Ended	12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017
Notes to Financial Statements
Stock purchase options issued	0	500,000
Warrants issued	725,000

9. FINANCIAL INSTRUMENTS (Detai

9. FINANCIAL INSTRUMENTS (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017
Gain (loss) from derivative instruments	$ 209,039	$ 11
Derivative expense	133,652	$ 0
Fair market value of the derivatives	$ 2,932,616		$ 2,145,065
Minimum [Member]
Estimated term	0 years
Estimated volatility	104.82%
Discount rate	0.96%
Maximum [Member]
Estimated term	5 years
Estimated volatility	174.38%
Discount rate	1.77%

10. FAIR VALUE MEASUREMENTS (De

10. FAIR VALUE MEASUREMENTS (Details) - USD ($)	Sep. 30, 2017	Jun. 30, 2017
Fair value of derivatives	$ 2,932,616	$ 2,145,065
Securities available-for-sale	47,940
Level 1 [Member]
Fair value of derivatives	0
Securities available-for-sale	47,940
Level 2 [Member]
Fair value of derivatives	0
Securities available-for-sale	0
Level 3 [Member]
Fair value of derivatives	2,932,616
Securities available-for-sale	$ 0

11. COMMITMENTS AND CONTINGEN40

11. COMMITMENTS AND CONTINGENCIES (Details)	Sep. 30, 2017USD ($)
Commitments And Contingencies Details
2,018	$ 127,561
2,019	141,464
2,020	131,475
2,021	87,287
2,022	0
Total	$ 487,786